Drug-induced QT interval prolongation in cancer patients
Cancer patients are at an increased risk for QT interval prolongation and subsequent potentially fatal Torsade de pointes tachycardia due to the multiple drugs used for treatment of malignancies and the associated symptoms and complications. Based on a systematic review of the literature, this artic...
Saved in:
Main Authors: | Torben K. Becker (Author), Sai-Ching J. Yeung (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2011-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cancer treatment and drug-induced QT interval prolongation: A review
by: Olga D. Ostroumova, et al.
Published: (2022) -
Effect of QT interval-prolonging drugs taken in pregnancy on the neonatal QT interval
by: Holger Michel, et al.
Published: (2023) -
Patient safety: prescription of drugs that prolong the QT interval
by: María Jesús Hernández-Arroyo, et al.
Published: (2015) -
Drug-induced prolonged corrected QT interval in patients with methadone and opium overdose
by: Davood Soroosh, et al.
Published: (2019) -
QT PRODACT: In Vivo QT Assay With a Conscious Monkey for Assessment of the Potential for Drug-Induced QT Interval Prolongation
by: Kentaro Ando, et al.
Published: (2005)